Global Balloon Catheter Market Report by Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Stent Graft Balloon Catheter, and Others), Indication (Coronary Artery Disease and Peripheral Vascular Disease), Raw Materials (Polyurethane, Nylon, and Others), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Diagnostic Centers), Country and Company Analysis 2024-2030

Global Balloon Catheter Market Analysis

Global Balloon Catheter Market size is expected to be about US$ 6.99 Billion by 2030. The CAGR for the global balloon catheter market from 2024 to 2030 is 6.73%. Renub Research said that it amounted to US$ 4.43 Billion in 2023.

Flexible medical devices, known as balloon catheters, have become essential resources for treating various vascular problems. These catheters are crucial tools for medical practitioners, helping them navigate the complexities of vascular health non-invasive and efficient during simple and complex treatments. An inflatable balloon is attached to the flexible tube tip of a balloon catheter. These catheters, made from cutting-edge medical-grade materials, undergo rigorous quality inspections to guarantee accuracy and security during medical procedures. A balloon catheter's construction is meticulously designed to satisfy the requirements of various medical situations. The inflating balloon acts as the focal point for various interventional treatments, and the flexible tube facilitates simple navigation across complex arterial paths.

Global Balloon Catheter Market Trends

• The United Nations states that the population of the globe has increased by more than three times since the middle of the 20th century. By mid-November 2022, there were 8.0 billion individuals on the globe. The world's population is predicted to rise by almost 2 billion people over the course of the next 30 years, from the present 8 billion to 9.7 billion in 2050, with a potential peak of roughly 10.4 billion in the middle of the 2080s. 
• The need for medical interventions is growing as the global population ages. The need for balloon catheters to treat age-related cardiovascular disease and other ailments drives the balloon catheter market worldwide.
• The American Heart Association on Heart Disease and Stroke Statistics states that patients between the ages of 40 and 60 had an average incidence of 35–40%, patients between the ages of 60 and 80 had an average incidence of 77–80%, and patients over 80 had an incidence of over 85%.
• The balloon catheter market is driven by the increasing prevalence of age-related cardiovascular diseases, improving the global treatment of an aging population.
• The Journal of the American Heart Association estimated that 55% to 98% of older persons (multimorbidity) have two or more chronic diseases. These individuals are 60 years of age or older. In multimorbid patients, CVDs are the most common ailments, and ischemic heart disease is one of the most common chronic diseases in individuals. The majority of older adults with CVD have other comorbidities. Just 17% of elderly coronary heart disease patients in one research had no other chronic illnesses. It is predicted that over two-thirds of individuals over 70 years old will also have related noncardiovascular comorbidities, with 70% of them expected to acquire CVD.
• A vital part of every medical device firm is lead generation. Technological developments in lead generation have the potential to enhance balloon catheter performance while reducing costs. Recent developments in the global balloon catheter market have focused on utilizing cutting-edge materials and technology to increase lead generation process efficacy. 
• More recently, highly personalized and precise lead structures for the balloon catheter industry have been made possible by applying cutting-edge technologies like 3D printing and laser cutting. This has resulted in better performance, lower expenses, and a shorter period from design to production.
• In November 2023 - at the Medtec Innovation Forum in Shanghai, China, on December 12–13, TekniPlex Healthcare leverages its expertise in advanced materials science to help improve patient outcomes, which will highlight its recently founded PTA/PTCA Balloon Catheter Tubing for coronary and non-coronary angioplasty procedures.

Asia-Pacific Balloon Catheter Market

The Asia-Pacific balloon catheter market is expected to grow due to the growth in the population and healthcare spending. Government and non-government organizations raising awareness about cardiovascular diseases will likely propel the balloon catheter industry.

• According to a Bain & Company survey, healthcare spending in Asia-Pacific is expected to expand at the quickest rate and account for over 20% of worldwide expenditure by 2030. However, access to care, cost, and quality remain significant obstacles for healthcare systems.
• In exchange for improved health outcomes, better experiences, and greater efficiency, almost half of all customers (or 58% of Gen Z) want to pay more for healthcare, according to this survey.
• In 2022, the age-standardized CVD death rates in High-income Asia-Pacific countries varied by 3.5 times, from 72.7 to 252.6 per 100,000.
• In June 2023 - The Asia-Pacific Cardiovascular Disease Alliance (APAC CVD Alliance) is a multisectoral coalition that aims to improve heart health and lower the burden of cardiovascular disease (CVD) across nine Asian health systems: Australia, China, India, Indonesia, Japan, Malaysia, South Korea, Thailand, and Vietnam. The coalition was formed by patient organizations, allied health professionals, academia, corporate partners, and a global health think tank. The secretariat of the APAC CVD Alliance is the worldwide health think tank ACCESS Health International, with its regional center for Southeast Asia located in Singapore.

Global Balloon Catheter Industry News

The companies that compete in the global balloon catheter market include Abbott Laboratories, Becton Dickinson and Company, Cardinal Health, Teleflex Incorporated, Medtronic Plc., Johnson and Johnson, Edwards Lifesciences Corporation, Stryker Corporation, and Smith & Nephew.

• In December 2023 - Summa Therapeutics said that the US Food and Drug Administration (FDA) has approved its novel line of injectable angioplasty balloon catheters for treating peripheral artery disease.
• In June 2023 - More options are now available for the Advance Serenity hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheter product line, as was disclosed at the Vascular Annual Meeting of the Society for Vascular Surgery (SVS). The Advance Serenity product is now available to interventionists doing peripheral intervention operations in the United States and Canada for both above-and below-the-knee treatments intended to treat patients suffering from peripheral arterial disease (PAD).
• In June 2023 - At LINC, the Leipzig Interventional Course, which took place in Leipzig, Germany from June 6–9, BIOTRONIK announced the limited distribution of its multipurpose peripheral catheter, Oscar® (One Solution: Cross. Adjust. Restore), as well as the beginning of promotional efforts.
• In May 2022 - The FDA approved the IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, a drug-coated balloon (DCB) intended for the interventional treatment of peripheral arterial disease (PAD) in the shallow femoral and popliteal arteries. Medtronic made this approval public.
• In April 2022 - The US market will soon witness the release of Nipro Medical Corporation's second-generation Cronus high-pressure (HP) percutaneous transluminal angioplasty (PTA) balloon catheter.

Product Type – Market breakup from 6 viewpoints:

1.    Normal Balloon Catheter
2.    Drug Eluting Balloon Catheter
3.    Cutting Balloon Catheter
4.    Scoring Balloon Catheter
5.    Stent Graft Balloon Catheter
6.    Others

Indication – Market breakup from 2 viewpoints:

1.    Coronary Artery Disease
2.    Peripheral Vascular Disease

Raw Materials – Market breakup from 3 viewpoints:

1.    Polyurethane
2.    Nylon
3.    Others

End-User – Market breakup from 4 viewpoints:

1.    Hospitals
2.    Clinics
3.    Ambulatory Surgical Centers
4.    Diagnostic Centers

Country – Market breakup from 26 Country Global Balloon Catheter Industry viewpoints:

1.    North America

1.1    United States
1.2    Canada

2.    Europe

2.1    France
2.2    Germany
2.3    Italy
2.4    Spain
2.5    United Kingdom
2.6    Belgium
2.7    Netherland
2.8    Turkey

3.    Asia Pacific

3.1    China
3.2    Japan
3.3    India
3.4    South Korea
3.5    Thailand
3.6    Malaysia
3.7    Indonesia
3.8    Australia
3.9    New Zealand

4.    Latin America

4.1    Brazil
4.2    Mexico
4.3    Argentina

5.    Middle East & Africa

5.1    Saudi Arabia
5.2    UAE
5.3    South Africa

6.    Rest of the World

All companies have been covered from 3 viewpoints:

•    Overview
•    Recent Developments
•    Revenue 

Company Analysis:

1.    Abbott Laboratories
2.    Becton Dickinson and Company
3.    Cardinal Health
4.    Teleflex Incorporated
5.    Medtronic Plc.
6.    Johnson and Johnson
7.    Edwards Lifesciences Corporation
8.    Stryker Corporation
9.    Smith & Nephew

Report Details: